ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $478,000 | +3314.3% | 25,332 | +2061.4% | 0.00% | – |
| Q2 2019 | $14,000 | +55.6% | 1,172 | +74.4% | 0.00% | – |
| Q1 2019 | $9,000 | -82.4% | 672 | -86.4% | 0.00% | – |
| Q4 2018 | $51,000 | -50.0% | 4,955 | -19.5% | 0.00% | -100.0% |
| Q3 2018 | $102,000 | +21.4% | 6,155 | +16.0% | 0.00% | 0.0% |
| Q2 2018 | $84,000 | -25.0% | 5,308 | -40.0% | 0.00% | 0.0% |
| Q1 2018 | $112,000 | +34.9% | 8,845 | +21.5% | 0.00% | 0.0% |
| Q4 2017 | $83,000 | -75.1% | 7,277 | -73.3% | 0.00% | -66.7% |
| Q3 2017 | $334,000 | +17.2% | 27,297 | +9.7% | 0.00% | 0.0% |
| Q2 2017 | $285,000 | – | 24,893 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $34,629,000 | 11.36% |
| Foresite Capital Management II, LLC | 1,586,220 | $18,670,000 | 10.50% |
| DAFNA Capital Management LLC | 636,013 | $7,486,000 | 2.81% |
| Redmile Group, LLC | 8,244,896 | $97,042,000 | 2.75% |
| Lion Point Capital, LP | 1,204,600 | $14,178,000 | 1.40% |
| Palo Alto Investors LP | 1,861,630 | $21,911,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,517,856 | $41,405,000 | 0.87% |
| Bellevue Group AG | 4,118,806 | $48,478,000 | 0.83% |
| Rock Springs Capital Management LP | 1,562,300 | $18,388,000 | 0.66% |
| Artal Group S.A. | 850,000 | $10,005,000 | 0.40% |